Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection-Reference-Cited by-同舟云学术

Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection

Published:2014-05-26 Issue:10 Volume:210 Page:1549-1554
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Sandler Netanya G.,Zhang Xinyan,Bosch Ronald J.,Funderburg Nicholas T.,Choi Andrew I.,Robinson Janet K.,Fine Derek M.,Coombs Robert W.,Jacobson Jeffrey M.,Landay Alan L.,Douek Daniel C.,Tressler Randall,Read Sarah W.,Wilson Cara C.,Deeks Steven G.,Lederman Michael M.,Gandhi Rajesh T.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/210/10/1549/18070500/jiu305.pdf

Reference15 articles.

1. Residual Immune Dysregulation Syndrome in Treated HIV infection

2. Microbial translocation in HIV infection: causes, consequences and treatment opportunities

3. Sevelamer Hydrochloride Use and Circulating Endotoxin in Hemodialysis Patients: A Pilot Cross-Sectional Study

4. Sevelamer Decreases Systemic Inflammation in Parallel to a Reduction in Endotoxemia

5. Effect of Phosphate Binders on Serum Inflammatory Profile, Soluble CD14, and Endotoxin Levels in Hemodialysis Patients

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiome and cardiometabolic comorbidities in people living with HIV;Microbiome;2024-06-14

2. Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives;Hellenic Journal of Cardiology;2023-05

3. Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV;Frontiers in Immunology;2023-04-21

4. HIV and comorbidities – the importance of gut inflammation and the kynurenine pathway;Current Opinion in HIV and AIDS;2022-12-28

5. HIV and cardiovascular disease: the role of inflammation;Current Opinion in HIV and AIDS;2022-07-05